6 Results for "

LynB

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "LynB" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-10209
CAS No.: 790299-79-5
Purity:  99.95%
Synonyms: AB1010
Research Areas:  

Cancer

Masitinib (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10209A
CAS No.: 1048007-93-7
Purity:  99.51%
Synonyms: AB-1010 mesylate
Target:  

c-Kit PDGFR Src FGFR Apoptosis

Research Areas:  

Cancer

Masitinib mesylate (AB-1010 mesylate) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib mesylate (AB-1010 mesylate) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
Cat. No.: HY-10209R
CAS No.: 790299-79-5
Synonyms: AB1010 (Standard)
Research Areas:  

Cancer

Masitinib (Standard) is the analytical standard of Masitinib. This product is intended for research and analytical applications. Masitinib (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
Cat. No.: HY-10209AR
CAS No.: 1048007-93-7
Synonyms: AB-1010 mesylate (Standard)
Research Areas:  

Cancer

Masitinib (mesylate) (Standard) is the analytical standard of Masitinib (mesylate). This product is intended for research and analytical applications. Masitinib mesylate (AB-1010 mesylate) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib mesylate (AB-1010 mesylate) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
Cat. No.: HY-10365
CAS No.: 592543-24-3
Research Areas:  

Cancer

ON012380 is a kinase inhibitor with an IC50 of 9 nM against BCR-ABL. As a substrate-competitive BCR-ABL inhibitor, ON012380 binds to a non-ATP site, and inhibits the kinase activities of PDGFR, Fyn and LynB at higher concentrations. ON012380 induces apoptosis, inhibits STAT-5 phosphorylation, reduces cell viability and suppresses cell growth in leukemia cells. ON012380 can be used in the research of chronic myeloid leukemia and Imatinib (HY-15463)-resistant chronic myeloid leukemia .
loading...
    loading...
Cat. No.: HY-P706066
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: LYN; Tyrosine-Protein Kinase Lyn; LYN Proto-Oncogene, Src Family Tyrosine Kinase; P53Lyn; JTK8; P56Lyn; V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog; Tyrosine-Protein Kinase; Lck/Yes-Related Novel Protein Tyrosine Kinase; SAIDV
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...